Related Experiment Video
Updated: Aug 17, 2026
Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
[The development of a new perimembranous ventricular septal defect occluder]
Zhi-wei Zhang1, Guo-hong Zeng, Shu-guang Lin
1Department of Pediatrics, Guangdong Cardiovascular Institute, Guangdong 510100, China.
Objective:
The aim of this study was to develop a new perimembranous VSD occluder and to evaluate it.
Methods:
The shape of VSD occluder was designed as fabric frame "I" shape that comprised two types: symmetric and asymmetric. The safety, efficacy, feasibility and complication were tested in 22 animal models and in 58 VSD patients in clinical trial. The device were compared with Amplatzer occluder in this study.
Results:
The new perimembranous VSD occluder was passed the national material test. In animal study, artificial VSD were all occluded by using the new devices with no complication in follow up except one pig expresented wound infection. In clinical trial, all 58 VSD cases were healing with the new device. One patient suffered with atria-ventricular block 5 days after procedure and was free from AV block with medicine therapy. Compared with Amplatzer perimembranous VSD occluder, the new devices had lower frequency of residual shunt.
Conclusion:
The new perimembranous VSD occluder is a safe and effective perimembranous VSD interventional apparatus, and the effect of the new occluders seems not worse than that of the Amplatzer ones.
